Abdulwahid M Salih1, F H Kakamad2, Yadkar A Saeed3, Aso S Muhialdeen3. 1. Faculty of Medical Sciences, School of Medicine, Department Surgery, University of Sulaimani, François Mitterrand Street, Sulaimani, Kurdistan Region, Iraq. 2. Faculty of Medical Sciences, School of Medicine, Department Cardiothoracic and Vascular Surgery, University of Sulaimani, François Mitterrand Street, Sulaimani, Kurdistan Region, Iraq; Bioscience Center, Hamdi Street, Sulaimani, Kurdistan Region, Iraq. Electronic address: fahmi.hussein@univsul.edu.iq. 3. Sulaimani Teaching Hospital, Sulaimani, Kurdistan Region, Iraq.
Abstract
INTRODUCTION: Metaplastic breast carcinoma (MBC) is a rare type of breast cancer. Osseous differentiation is a very rare subtype. Reporting this kind of case is important because its clinical course and line of management are poorly mentioned in the literatures. We present a very rare case of MBC with osseous differentiation. A 48-year-old female presented with painless hard mass of the left breast. Examination and investigations showed MBC with osseous differentiation. She was managed by operation with adjuvant chemotherapy. CONCLUSION: MBC with osseous differentiation is a very rare type of breast carcinoma presenting with hard mass and managed by mastectomy, axillary lymph node sampling and adjuvant chemotherapy.
INTRODUCTION:Metaplastic breast carcinoma (MBC) is a rare type of breast cancer. Osseous differentiation is a very rare subtype. Reporting this kind of case is important because its clinical course and line of management are poorly mentioned in the literatures. We present a very rare case of MBC with osseous differentiation. A 48-year-old female presented with painless hard mass of the left breast. Examination and investigations showed MBC with osseous differentiation. She was managed by operation with adjuvant chemotherapy. CONCLUSION:MBC with osseous differentiation is a very rare type of breast carcinoma presenting with hard mass and managed by mastectomy, axillary lymph node sampling and adjuvant chemotherapy.
Authors: Riaz A Agha; Alexander J Fowler; Alexandra Saeta; Ishani Barai; Shivanchan Rajmohan; Dennis P Orgill Journal: Int J Surg Date: 2016-09-07 Impact factor: 6.071
Authors: Xue Chao; Wanlin Tan; Julia Y Tsang; Gary M Tse; Jintao Hu; Ping Li; Jinghui Hou; Mei Li; Jiehua He; Peng Sun Journal: Breast Cancer Date: 2021-05-03 Impact factor: 4.239